Build Lasting Connections with Industry Experts Developing Cell & Gene Therapies for Inner Ear Hearing Disorders

This is your premium opportunity to meet and network with senior decision makers from new gene therapy companies such as Sensorion, Refreshgene Therapeutics, Acousia Therapeutics, Gateway Biotechnology and Regeneron Pharmaceuticals. Show them how your services are vital for them to accelerate their gene therapy pipelines for rare genetic hearing loss.

This Niche Community of Auditory R&D Experts Seek:

Audiology & Biomarker Services

Preclinical CROs With Safety & Toxicity Services

Pathology Services

Preclinical Models For Hearing Disorders

Clinical CROs With Expertise In Inner Ear & Auditory Sciences

Why Partner?

Hear the Latest Developments in Inner Ear Drug Discovery

Discover new hearing loss therapeutics developed by industry experts, such as Refreshgene Therapeutics, Ting Therapeutics and Spiral Therapeutics, and refresh your target client list with new contacts

Establish Key Contacts with Industry Experts from Acousia Therapeutics, Sensorion, Lineage Cell Therapeutics & Regeneron

Secure precious facetime with key decision makers from the top biotech and pharma companies in the field as they require better preclinical, biomarker, pathology and clinical services to progress their drug

Generate Commercial Collaborations with New Companies Joining the Inner Ear Space

Build a wish list and have them contacted in advance to ensure that your hottest prospects are present in the room and you are all set up for success in securing top quality leads for desired commercial growth

Raise Brand Awareness within the Otolaryngology & Auditory Sciences Community

Expand your market share with key experts working on developing genetic and common hearing loss therapeutics through unique branding formats such as event branding, lead partnership options, dedicated presentations or an exhibition booth, to showcase your services in the best way possible

Audience Breakdown: